Disposable Aseptic Isolation Systems Market size was valued at USD 1.26 billion in 2023 and is likely to reach USD 2.65 billion by 2036, expanding at around 5.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of disposable aseptic isolation systems is assessed at USD 1.32 billion. The growth of the market can be attributed to the increase in production and employment in healthcare services. As per the U.S Bureau of Labor Statistics, total employment is estimated to raise up to 16% over the decade (2020-2030) with an increase of 2.6 million jobs. Additionally, the introduction of the latest products, technological advancements, and innovations in disposable aseptic isolation systems impacted the growth of the market.
Further, the increased implementation of safe and contamination-free drugs during COVID-19 has created numerous growth opportunities for the disposable aseptic isolation systems market. Companies in the field of aseptic isolator systems took the opportunity to produce more products and increase the availability of their products thus increasing the market growth. Additionally, the increase in the contribution made by the biopharmaceutical industry in the development of the world’s healthcare sector is projected to upsurge the market growth. The worldwide sales of biopharmaceutical products had shown a drastic growth in value from around USD 100 in 2001 to USD about 600 in 2018.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
5.9% |
|
Base Year Market Size (2023) |
USD 1.26 billion |
|
Forecast Year Market Size (2036) |
USD 2.65 billion |
|
Regional Scope |
|
The global disposable aseptic isolation systems market is segmented and analyzed for demand and supply by end-user into pharmaceutical companies, hospitals, chemical industry, research institutes, biosafety laboratories, and others. Out of which, the pharmaceutical companies segment is anticipated to hold the largest market size by the end of 2031 on account of growing demand for pharmaceutical isolators in the pharmaceutical and biotechnological industries during the forecast period. Moreover, the increasing regulations, usage of aseptic methods, growing research laboratories, cost of noncompliance, rising usage of harmful materials, and advancements in the efficiency of isolators are expected to be major growth factors. The research and development expenditure (in GDP %) in 2021 amounted to 2.63% up from 2.13% in 2017.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
|
By End-User |
|
Regionally, the global disposable aseptic isolation systems market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is expected to dominate majority revenue share by 2036, attributed to great hold in the dominating position of the manufacturing industry, adoption of disposable aseptic isolation systems in the field of biopharmaceuticals, and rise of investment in medicines and healthcare. As per the IFMA report 2021, the global spending of the United States on medicines will increase from USD 485 billion in 2018 to USD 625-655 billion in 2023.
Berkshire Sterile Manufacturing introduced a new technology to decontaminate RTU tubs for sterility assurance during filling operations thereby reducing the risk of contamination.
Getinge AB provides at-home care for cancer patients in coordination with Sciensus. They together made GMP ISOFLEX-R aseptic isolators with a DPTE transfer system that uses RTP or alpha-beta transfer port with no leakage and risk-free connectivity.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?